HHS Sec. Robert F. Kennedy’s vaccine skepticism and removal of CDC advisory panel members challenged by experts Plotkin, Offit & others who say he misunderstands placebo science.

Vaxart’s stock price shot up Wednesday after releasing new data in the same week that vaccine R&D is the focus of attention.

FDA Commissioner Marty Makary said he wasn’t involved in Robert F. Kennedy Jr.’s decision to fire every member of a key CDC expert panel that guides national vaccine policy.

The FDA’s infusion of a political appointee into the approval decision for Novavax’s Covid-19 vaccine

Sanofi to deliver RSV drug Beyfortus early before November season; faces potential competition from Merck’s clesrovimab awaiting FDA approval. Both are antibodies for infant protection.

→ GSK has made a key hire for a crucial part of its business, appointing Sanjay Gurunathan as global head of vaccines and infectious disease R&D. Over the course of …

The FDA and CDC’s decision last month to pause administering Valneva’s live-attenuated chikungunya vaccine in patients 60 and older was meant to provide more time to examine a potential causal …